Evidence map›Paper›PMID 31712740›Full record

ArticleScientific reports2019

Reliable variant calling during runtime of Illumina sequencing.

Tobias P Loka, Simon H Tausch, Bernhard Y Renard

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tobias P LokaBioinformatics Division (MF 1), Department for Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0001-6380-5875
Simon H TauschBioinformatics Division (MF 1), Department for Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany.ORCID http://orcid.org/0000-0002-6874-233X
Bernhard Y RenardBioinformatics Division (MF 1), Department for Methodology and Research Infrastructure, Robert Koch Institute, Berlin, Germany. RenardB@rki.de.ORCID http://orcid.org/0000-0003-4589-9809

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sequential paradigm of data acquisition and analysis in next-generation sequencing leads to high turnaround times for the generation of interpretable results. We combined a novel real-time read mapping algorithm with fast variant calling to obtain reliable variant calls still during the sequencing process. Thereby, our new algorithm allows for accurate read mapping results for intermediate cycles and supports large reference genomes such as the complete human reference. This enables the combination of real-time read mapping results with complex follow-up analysis. In this study, we showed the accuracy and scalability of our approach by applying real-time read mapping and variant calling to seven publicly available human whole exome sequencing datasets. Thereby, up to 89% of all detected SNPs were already identified after 40 sequencing cycles while showing similar precision as at the end of sequencing. Final results showed similar accuracy to those of conventional post-hoc analysis methods. When compared to standard routines, our live approach enables considerably faster interventions in clinical applications and infectious disease outbreaks. Besides variant calling, our approach can be adapted for a plethora of other mapping-based analyses.

Indexed as

Genetic VariationHigh-Throughput Nucleotide SequencingSequence Analysis, DNASoftwareAlgorithmsComputational BiologyExome SequencingHumansReproducibility of ResultsWorkflow

Identifiers

PMID31712740
PMCPMC6848508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.